2-DG Drug

New collaboration for affordable COVID-19 drug 2-DG

New Delhi: Indian Institute of Chemical Technology (IICT), Hyderabad, a constituent laboratory of Council of Scientific and Industrial Research (CSIR), New Delhi, and Nosch Labs entered into a non-exclusive agreement for the transfer of the process knowhow for the synthesis of anti-Covid-19 drug 2-DG (2-Deoxy -D -Glucose). 2-DG has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), New Delhi, a lab of the Defence Research and Development Organisation (DRDO), in collaboration with Hyderabad-based pharma company Dr Reddy’s Laboratories (DRL). Nosch Labs will commence manufacturing 2-DG drug after obtaining regulatory clearances from the Drugs Controller General of India…
Read More

DRDO lab develops antibody test kit for COVID-19

New Delhi: Defence Research and Development Organisation (DRDO) scientists have now got a new breakthrough after developing COVID-19 drug 2-DG. Institute of Physiology and Allied Sciences (DIPAS), a DRDO laboratory, has now developed an antibody detection-based kit 'DIPCOVAN', the DIPAS-VDx COVID-19 IgG Antibody Microwell ELISA for sero-surveillance. The kit has been developed in association with New Delhi based company, Vanguard Diagnostics Pvt Ltd. DIPCOVAN kit can detect both spike as well as nucleocapsid proteins of SARS-CoV-2 virus with a high sensitivity of 97 per cent and specificity of 99 per cent. DIPCOVAN kit was developed indigenously followed by extensive validation…
Read More